PE20091332A1 - Polvo nutricional estable - Google Patents

Polvo nutricional estable

Info

Publication number
PE20091332A1
PE20091332A1 PE2008002092A PE2008002092A PE20091332A1 PE 20091332 A1 PE20091332 A1 PE 20091332A1 PE 2008002092 A PE2008002092 A PE 2008002092A PE 2008002092 A PE2008002092 A PE 2008002092A PE 20091332 A1 PE20091332 A1 PE 20091332A1
Authority
PE
Peru
Prior art keywords
hydrolyzed
weight
nutrition powder
powder
total
Prior art date
Application number
PE2008002092A
Other languages
English (en)
Inventor
Christine L Clinger
Jeffrey M Boff
Paul W Johns
Gary W Katz
Marti S Bergana
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40788959&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20091332(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of PE20091332A1 publication Critical patent/PE20091332A1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17Amino acids, peptides or proteins
    • A23L33/18Peptides; Protein hydrolysates
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/10Foods or foodstuffs containing additives; Preparation or treatment thereof containing emulsifiers

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mycology (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Dairy Products (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

REFERIDA A UNA COMPOSICION BAJO LA FORMA DE POLVO QUE COMPRENDE: a) CARBOHIDRATOS, b) LIPIDOS, QUE COMPRENDEN ENTRE 0,25% Y 2,5% DE LECITINA EN PESO DE LIPIDOS TOTALES, c) ENTRE 90% Y 99,5% DE PROTEINAS INTACTAS EN PESO DE PROTEINAS TOTALES, d) ENTRE 0,5% Y 10% DE UNA PROTEINA HIDROLIZADA EN PESO DE PROTEINAS TOTALES TAL COMO CASEINA HIDROLIZADA Y PROTEINA DE SUERO HIDROLIZADA, DONDE LA PROTEINA HIDROLIZADA TIENE UN GRADO DE HIDROLISIS DE ENTRE 23% Y 90%. DICHA COMPOSICION ES UTIL COMO UN POLVO NUTRICIONAL
PE2008002092A 2007-12-20 2008-12-17 Polvo nutricional estable PE20091332A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US1531807P 2007-12-20 2007-12-20

Publications (1)

Publication Number Publication Date
PE20091332A1 true PE20091332A1 (es) 2009-09-30

Family

ID=40788959

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2008002092A PE20091332A1 (es) 2007-12-20 2008-12-17 Polvo nutricional estable

Country Status (25)

Country Link
US (1) US8377496B2 (es)
EP (1) EP2242382B1 (es)
JP (1) JP2011507518A (es)
CN (1) CN101951789B (es)
AR (1) AR070679A1 (es)
AU (1) AU2008343689A1 (es)
BR (1) BRPI0820584A2 (es)
CA (1) CA2708527C (es)
CL (1) CL2008003809A1 (es)
CO (1) CO6280447A2 (es)
CR (1) CR11508A (es)
DO (1) DOP2010000176A (es)
EC (1) ECSP10010262A (es)
GT (1) GT201000173A (es)
IL (1) IL206132A (es)
MX (1) MX2010006887A (es)
MY (1) MY168206A (es)
NZ (1) NZ585619A (es)
PA (1) PA8808701A1 (es)
PE (1) PE20091332A1 (es)
RU (1) RU2481008C2 (es)
SV (1) SV2010003599A (es)
TW (1) TWI418307B (es)
WO (1) WO2009085388A2 (es)
ZA (1) ZA201003912B (es)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8097245B2 (en) 2005-12-28 2012-01-17 Advanced Bionutrition Corporation Delivery vehicle for probiotic bacteria comprising a dry matrix of polysaccharides, saccharides and polyols in a glass form and methods of making same
CA2673120C (en) 2006-12-18 2012-08-07 Advanced Bionutrition Corporation A dry food product containing live probiotic
US20090258833A1 (en) * 2008-04-10 2009-10-15 Edward Walker Fortified liquid protein compositions and methods of making same
WO2010111565A2 (en) 2009-03-27 2010-09-30 Advanced Bionutrition Corporation Microparticulated vaccines for the oral or nasal vaccination and boostering of animals including fish
EP3563842A1 (en) 2009-04-29 2019-11-06 Amarin Pharmaceuticals Ireland Limited Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same
NO2424356T3 (es) 2009-04-29 2018-01-20
PL2435554T3 (pl) 2009-05-26 2018-01-31 Advanced Bionutrition Corp Stabilna kompozycja suchego proszku zawierająca biologicznie aktywne mikroorganizmy i/lub materiały bioaktywne i sposoby jej wykonania
ES2661217T3 (es) 2009-06-15 2018-03-28 Amarin Pharmaceuticals Ireland Limited Composiciones y métodos para reducir los triglicéridos sin aumentar los niveles de LDL-C en un sujeto en terapia simultánea con estatinas
TW201112967A (en) * 2009-09-16 2011-04-16 Abbott Lab Dryblended nutritional powders
WO2011038122A1 (en) 2009-09-23 2011-03-31 Amarin Corporation Plc Pharmaceutical composition comprising omega-3 fatty acid and hydroxy-derivative of a statin and methods of using same
US9504750B2 (en) 2010-01-28 2016-11-29 Advanced Bionutrition Corporation Stabilizing composition for biological materials
AR080073A1 (es) 2010-01-28 2012-03-14 Advanced Bionutrition Corp Composicion vitrea seca que comprende un material bioactivo
US8840950B2 (en) * 2010-05-26 2014-09-23 Jacqueline M. Hibbert Compositions of nutrition supplementation for nutritional deficiencies and method of use therefore
BR112013003244B1 (pt) 2010-08-13 2018-07-17 Advanced Bionutrition Corp composição seca estabilizante para material biológico, seu método de preparação, e formulação de carreamento oral
EP2646013A4 (en) 2010-11-29 2014-03-26 Amarin Pharma Inc COMPOSITION WITH LOW IMPACT EFFECT AND METHOD FOR THE TREATMENT AND / OR PREVENTION OF CARDIOVASCULAR DISEASES IN A PATIENT WITH FISH ALLERGY / SENSITIVITY
US11712429B2 (en) 2010-11-29 2023-08-01 Amarin Pharmaceuticals Ireland Limited Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity
CN102599402B (zh) * 2011-01-25 2013-09-04 光明乳业股份有限公司 一种乳清蛋白组合物及其制备方法
WO2012109105A1 (en) * 2011-02-07 2012-08-16 Abbott Laboratories Nutritional products comprising beta-hydroxy-beta-methylbutyrate
CN102273520B (zh) * 2011-08-02 2013-08-07 中国科学院新疆理化技术研究所 乳清营养粉及其制备方法
US20130089638A1 (en) * 2011-10-11 2013-04-11 Mead Johnson Nutrition Company Compositions Comprising Maltotriose And Methods Of Using Same To Inhibit Damage Caused By Dehydration Processes
MX370851B (es) * 2011-10-14 2020-01-08 Abbott Lab Suplemento de proteína líquida esterilizada.
US11291643B2 (en) 2011-11-07 2022-04-05 Amarin Pharmaceuticals Ireland Limited Methods of treating hypertriglyceridemia
US20130131170A1 (en) 2011-11-07 2013-05-23 Amarin Pharmaceuticals Ireland Limited Methods of treating hypertriglyceridemia
JP6307442B2 (ja) 2012-01-06 2018-04-04 アマリン ファーマシューティカルス アイルランド リミテッド 対象の高感度(hs−crp)のレベルを低下させる組成物および方法
AU2013234931B2 (en) * 2012-03-23 2017-12-07 Intervet International Bv Stabilizing composition for biological materials
MA50258A1 (fr) 2012-06-29 2023-07-31 Amarin Pharmaceuticals Ie Ltd Procédés de réduction du risque d'un événement cardiovasculaire chez un sujet soumis à un traitement par une statine
WO2014074552A2 (en) 2012-11-06 2014-05-15 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering triglycerides without raising ldl-c levels in a subject on concomitant statin therapy
US20140187633A1 (en) 2012-12-31 2014-07-03 Amarin Pharmaceuticals Ireland Limited Methods of treating or preventing nonalcoholic steatohepatitis and/or primary biliary cirrhosis
US9452151B2 (en) 2013-02-06 2016-09-27 Amarin Pharmaceuticals Ireland Limited Methods of reducing apolipoprotein C-III
US9624492B2 (en) 2013-02-13 2017-04-18 Amarin Pharmaceuticals Ireland Limited Compositions comprising eicosapentaenoic acid and mipomersen and methods of use thereof
US20140271841A1 (en) 2013-03-15 2014-09-18 Amarin Pharmaceuticals Ireland Limited Pharmaceutical composition comprising eicosapentaenoic acid and derivatives thereof and a statin
US20140328970A1 (en) * 2013-05-03 2014-11-06 Mead Johnson Nutrition Company Nutritional Composition Comprising Whey and Hydrolyzed Casein and Uses Thereof
US10966968B2 (en) 2013-06-06 2021-04-06 Amarin Pharmaceuticals Ireland Limited Co-administration of rosiglitazone and eicosapentaenoic acid or a derivative thereof
US20150065572A1 (en) 2013-09-04 2015-03-05 Amarin Pharmaceuticals Ireland Limited Methods of treating or preventing prostate cancer
US9585859B2 (en) 2013-10-10 2017-03-07 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering triglycerides without raising LDL-C levels in a subject on concomitant statin therapy
US10639334B2 (en) * 2014-01-07 2020-05-05 Mead Johnson Nutrition Company Pediatric nutritional composition with milk peptides for healthy growth and development
US10561631B2 (en) 2014-06-11 2020-02-18 Amarin Pharmaceuticals Ireland Limited Methods of reducing RLP-C
WO2015195662A1 (en) 2014-06-16 2015-12-23 Amarin Pharmaceuticals Ireland Limited Methods of reducing or preventing oxidation of small dense ldl or membrane polyunsaturated fatty acids
WO2016014514A1 (en) * 2014-07-21 2016-01-28 Abbott Laboratories Nutritional powder with polyunsaturated fatty acid and improved organoleptic properties
EP3171713A1 (en) * 2014-07-21 2017-05-31 Abbott Laboratories Nutritional powder with specific antioxidants
CN107205448A (zh) * 2015-01-16 2017-09-26 威尔君克斯有限公司 含胶原蛋白和附加添加剂的饮料
JP6889699B2 (ja) 2015-07-29 2021-06-18 アドバンスド バイオニュートリション コープ. 特定栄養用途のための安定乾燥プロバイオティクス組成物
ES2964285T3 (es) * 2015-10-15 2024-04-05 Nutricia Nv Fórmula para lactantes con grasa láctea para promover un crecimiento saludable
WO2017117121A1 (en) 2015-12-28 2017-07-06 Abbott Laboratories Nutritional compositions comprising hydrolyzed protein and a modified fat system and uses thereof
JP2019503694A (ja) * 2016-02-05 2019-02-14 アボット・ラボラトリーズAbbott Laboratories 乳清タンパク質系液体栄養組成物
US10406130B2 (en) 2016-03-15 2019-09-10 Amarin Pharmaceuticals Ireland Limited Methods of reducing or preventing oxidation of small dense LDL or membrane polyunsaturated fatty acids
WO2018213663A1 (en) 2017-05-19 2018-11-22 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering triglycerides in a subject having reduced kidney function
US11197917B2 (en) 2017-12-01 2021-12-14 ByHeart, Inc. Formulations for nutritional support in subjects in need thereof
US11058661B2 (en) 2018-03-02 2021-07-13 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering triglycerides in a subject on concomitant statin therapy and having hsCRP levels of at least about 2 mg/L
EP3700518A4 (en) 2018-09-24 2020-12-16 Amarin Pharmaceuticals Ireland Limited METHODS FOR REDUCING THE RISK OF CARDIOVASCULAR EVENTS IN A SUBJECT
SG11202109062TA (en) * 2019-02-21 2021-09-29 Ingenuity Foods Inc Compositions comprising choline and omega-3 fatty acid to nutritionally enhance food products
EP4326244A1 (en) 2021-04-21 2024-02-28 Amarin Pharmaceuticals Ireland Limited Methods of reducing the risk of heart failure
CN113632993A (zh) * 2021-08-24 2021-11-12 黑龙江八一农垦大学 黑豆-乳清双蛋白运动营养粉

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5024849A (en) 1990-05-01 1991-06-18 Nestec S.A. Liquid coffee whitener
US5021245A (en) 1990-05-22 1991-06-04 Abbott Laboratories Infant formula containing a soy polysaccharide fiber source
CA2089920C (en) 1992-02-21 1999-06-15 John D. Johnston Synergistic compositions for extending animal feed shelf life
NL9300848A (nl) 1993-05-14 1994-12-01 Friesland Frico Domo Coop Werkwijze voor de bereiding van lang houdbare melkconcentraten en melkpoeders.
US5405637A (en) * 1993-06-30 1995-04-11 Bristol-Myers Squibb Company Milk protein partial hydrolysate and infant formula containing same
US6136858A (en) * 1994-01-10 2000-10-24 Abbott Laboratories Infant formula and methods of improving infant stool patterns
NZ278778A (en) * 1994-01-10 1998-10-28 Abbott Lab Enteral nutritional formula comprising nucleotide equivalents together with carbohydrates, lipids, proteins, vitamins, and minerals
US5635199A (en) 1995-10-27 1997-06-03 Nestec Ltd. Support of pediatric patients
DK1039892T3 (da) 1997-02-21 2004-08-30 Univ Tennessee Res Foundation Anvendelse af polyumættede fedtsyrer til reducering af forekomsten af nekrotiserende enterocolitis
EP1034704A1 (en) 1999-03-12 2000-09-13 Societe Des Produits Nestle S.A. Nutritional composition intended for specific gastro-intestinal maturation in premature mammals
US6294206B1 (en) 1999-04-09 2001-09-25 Abbott Laboratories Powdered human milk fortifier
US6365218B1 (en) 2000-02-04 2002-04-02 Abbott Laboratories Pediatric formula and methods for providing nutrition and improving tolerance
US6207638B1 (en) * 2000-02-23 2001-03-27 Pacifichealth Laboratories, Inc. Nutritional intervention composition for enhancing and extending satiety
ATE369045T1 (de) * 2001-11-26 2007-08-15 Nestec Sa Lagerstabiles nahrungsmittelprodukt enthaltend molkenprotein, verfahren zu seiner herstellung und verwendung
RU2262867C2 (ru) * 2002-02-14 2005-10-27 Катков Юрий Адольфович Бад к пище для улучшения репродукции человека (варианты)
US7070825B2 (en) 2002-09-10 2006-07-04 Abbott Laboratories Infant formula
TWI317636B (en) 2002-11-22 2009-12-01 Meiji Dairies Corp Nutritional compositions for liver disease patients or for patients underhigh levels of invasive stress
WO2005089255A2 (en) 2004-03-12 2005-09-29 Nellson Northern Operating Inc. Novel protein layering masses, processes for the manufacture thereof, and related products
CA2537647A1 (en) 2005-03-01 2006-09-01 Six Star Formulations Ltd. Supplemental dietary composition for supporting muscle growth, recovery and strength
US20060233915A1 (en) 2005-04-15 2006-10-19 Bristol-Myers Squibb Company Liquid nutritional product to supplement human milk
US7618669B2 (en) 2005-06-01 2009-11-17 Mead Johnson Nutrition Company Low-lactose partially hydrolyzed infant formula
DE102005031468A1 (de) 2005-07-04 2007-01-18 Basf Ag Wässrige Suspensionen schwer wasserlöslicher oder wasserunlöslicher Wirkstoffe und daraus hergestellte Trockenpulver
RU2420210C2 (ru) 2006-03-23 2011-06-10 Нестек С.А. Высококалорийная питательная добавка
ES2373400T3 (es) 2006-03-27 2012-02-03 Nestec S.A. Micelas de proteína láctea.
US7875303B2 (en) 2006-03-31 2011-01-25 Kraft Foods Global Brands Llc Protein system and food products including same
US20070281054A1 (en) 2006-05-31 2007-12-06 Abbott Laboratories Organic powder nutritional formula containing select carbohydrate combinations
WO2010047581A1 (en) 2008-10-24 2010-04-29 N.V. Nutricia Liquid high-fat protein composition

Also Published As

Publication number Publication date
MX2010006887A (es) 2010-10-15
US20090162518A1 (en) 2009-06-25
RU2010129984A (ru) 2012-01-27
ZA201003912B (en) 2011-06-29
WO2009085388A3 (en) 2010-09-02
CR11508A (es) 2011-08-12
TW200932128A (en) 2009-08-01
EP2242382B1 (en) 2016-11-16
CA2708527A1 (en) 2009-07-09
CN101951789B (zh) 2014-02-05
NZ585619A (en) 2012-06-29
AR070679A1 (es) 2010-04-28
PA8808701A1 (es) 2009-07-23
MY168206A (en) 2018-10-15
WO2009085388A2 (en) 2009-07-09
GT201000173A (es) 2012-04-03
CN101951789A (zh) 2011-01-19
EP2242382A2 (en) 2010-10-27
IL206132A0 (en) 2010-11-30
CO6280447A2 (es) 2011-05-20
IL206132A (en) 2014-04-30
RU2481008C2 (ru) 2013-05-10
ECSP10010262A (es) 2010-07-30
SV2010003599A (es) 2011-01-24
AU2008343689A1 (en) 2009-07-09
BRPI0820584A2 (pt) 2015-07-14
US8377496B2 (en) 2013-02-19
CA2708527C (en) 2016-06-14
CL2008003809A1 (es) 2009-10-16
JP2011507518A (ja) 2011-03-10
DOP2010000176A (es) 2010-10-15
TWI418307B (zh) 2013-12-11

Similar Documents

Publication Publication Date Title
PE20091332A1 (es) Polvo nutricional estable
DOP2010000174A (es) Polvo nutricional estable
CY1125697T1 (el) Σταθερες, υδατικες φαρμακοτεχνικες μορφες αντισωματων
MX2019011952A (es) Proteina anti-garp y sus usos.
PE20151765A1 (es) Formulas a base de hidrolizado de aminoacido y proteina con un sistema estable de emulsion
IN2015DN04226A (es)
CL2015002517A1 (es) Proteínas de unión a antígeno.
ECSP12012045A (es) Emulsiones nutricionales que comprenden beta-hidroxi-beta-metilbutirato (hmb)de calcio y proteína soluble
WO2013184938A3 (en) Fusion polypeptides comprising mucin-domain polypeptide linkers
CL2011000893A1 (es) Composicion nutricional para infantes en que comprende proteinas parcialmente hidrolizadas con un grado de hidrolisis de entre 5 y 40%, una fuente de lipido y una fuente de carbohidrato seleccionado entre almidon de cereal o de papa; y su uso para el manejo de la regurgitacion.
CL2007002084A1 (es) Ingrediente lacteo enriquecido en fosfolipidos y esfingolipidos, en que el porcentaje de fosfolipidos es mayor a 36% con respeto al peso de la materia seca del ingrediente; procedimiento de obtencion; composicion alimentaria o aditivo que lo contiene; composicion farmaceutica o cosmetica; y su uso.
MY184736A (en) Compositions and methods containing alkylglycosides for stabilizing protein-containing formulations
MX353777B (es) Composiciones nutricionales de suero-caseina parcialmente hidrolizadas para reducir la aparicion de alergias.
PH12016500894A1 (en) Pediatric nutritional composition with milk peptides for healthy growth and development
PH12015500049B1 (en) Novel protein material
BR112016028922A2 (pt) composição na forma de partículas compactadas e seu uso
AR099344A1 (es) Composición nutricional que comprende suero y caseína hidrolizada
TWD181452S (zh) 電連接器
BR112013012390A8 (pt) Hidrolisado de proteína hidrofobizada
TWD181276S (zh) 電連接器
TH115365A (th) ผงที่มีสารอาหาร ที่คงตัว
TH115364A (th) ผงที่มีสารอาหาร ที่คงตัว
PL402190A1 (pl) Substytut śliny naturalnej
UA114039C2 (uk) Білоквмісна композиція з яловичим колагеновим білком
TH119529S (th) ตัวเรือนข้อต่อไฟฟ้า

Legal Events

Date Code Title Description
FC Refusal